Oct 8, 2021
Divi’s Laboratories rating – Buy: Covid-19 drug could lead to a windfall
If authorised, it will be the first oral COVID-19 drug which can be taken at home (current treatments, e.g. remdesivir, require access to a healthcare facility). Merck (also known as MSD outside the US and Canada) and partner Ridgeback Biotherapeutics announced strong results from the interim analysis of Phase 3 trials for molnupiravir (experiment oral treatment for COVID-19). Per MSD,…
View On WordPress